RxSight announced inducement stock options and restricted stock units for new President and CEO Aziz Mottiwala. The options cover 571,286 shares at $5.19 per share, vesting 25% after one year and monthly thereafter over four years. The RSUs cover 2,312,138 shares, vesting 20% after one year, 20% after two years, and 60% after three years. The awards were granted under the 2026 Inducement Equity Incentive Plan as material inducements for his employment, in compliance with Nasdaq Listing Rule 5635(c)(4).
Rxsight IncGrant of inducement equity awards to new CEO, which is a standard compensation event with no clear directional signal for the company's performance.